miR-1182 inhibits growth and mediates the chemosensitivity of bladder cancer by targeting hTERT

被引:39
作者
Zhou, Jun [1 ]
Dai, Wenbin [1 ]
Song, Jianming [2 ]
机构
[1] Fudan Univ, Huadong Hosp, Dept Urol, 221 Yan An Rd W, Shanghai 200040, Peoples R China
[2] Oregon Hlth & Sci Univ, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA
关键词
miR-1182; hTERT; Bladder cancer; Chemosensitivity; CISPLATIN CHEMORESISTANCE; UP-REGULATION; CELLS; PROLIFERATION; MICRORNAS; METASTASIS; SUPPRESSES; BIOMARKERS;
D O I
10.1016/j.bbrc.2016.01.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
microRNAs (miRNAs) have been demonstrated to contribute to tumor progression and metastasis and proposed to be key regulators of diverse biological processes. In this study, we report that miR-1182 is deregulated in bladder cancer tissues and cell lines. To characterize the role of miR-1182 in bladder cancer cells, we performed functional assays. The overexpression of miR-1182 significantly inhibits bladder cancer cell proliferation, colony formation, and invasion. Moreover, its up-regulation induced cell cycle arrest and apoptosis and mediated chemosensitivity to cisplatin in bladder cancer. Furthermore, a luciferase reporter assay and a rescue experiment indicated that miR-1182 directly targets hTERT by binding its 3'UTR. In conclusion, these results demonstrate that miR-1182 acts as a tumor suppressor and may be a potential biomarker for bladder cancer diagnosis and treatment. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:445 / 452
页数:8
相关论文
共 39 条
[1]   Akt confers cisplatin chemoresistance in human gynecological carcinoma cells by modulating PPM1D stability [J].
Ali, Ahmed Y. ;
Kim, Ji-Young ;
Pelletier, Jean-Francois ;
Vanderhyden, Barbara C. ;
Bachvarov, Dimcho R. ;
Tsang, Benjamin K. .
MOLECULAR CARCINOGENESIS, 2015, 54 (11) :1301-1314
[2]   Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review) [J].
Allegra, Alessandro ;
Alonci, Andrea ;
Campo, Salvatore ;
Penna, Giuseppa ;
Petrungaro, Annamaria ;
Gerace, Demetrio ;
Musolino, Caterina .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (06) :1897-1912
[3]  
[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
[4]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[5]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[6]   Telomerase at the intersection of cancer and aging [J].
Bernardes de Jesus, Bruno ;
Blasco, Maria A. .
TRENDS IN GENETICS, 2013, 29 (09) :513-520
[7]   MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review [J].
Catto, James W. F. ;
Alcaraz, Antonio ;
Bjartell, Anders S. ;
White, Ralph De Vere ;
Evans, Christopher P. ;
Fussel, Susanne ;
Hamdy, Freddie C. ;
Kallioniemi, Olli ;
Mengual, Lourdes ;
Schlomm, Thorsten ;
Visakorpi, Tapio .
EUROPEAN UROLOGY, 2011, 59 (05) :671-681
[8]   miR-485-5p inhibits bladder cancer metastasis by targeting HMGA2 [J].
Chen, Zhijun ;
Li, Qingwen ;
Wang, Sheng ;
Zhang, Jiajun .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 (04) :1136-1142
[9]   MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy [J].
Cho, William C. S. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (08) :1273-1281
[10]   The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer [J].
Deng, Hui ;
Lv, Lei ;
Li, Yang ;
Zhang, Cheng ;
Meng, Fang ;
Pu, Youguang ;
Xiao, Jun ;
Qian, Liting ;
Zhao, Weidong ;
Liu, Qi ;
Zhang, Daming ;
Wang, Yingwei ;
Zhang, Hongyu ;
He, Yinghua ;
Zhu, Jingde .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (03) :520-528